(Q39428601)

11 September 2017

title

Milrinone for long-term pharmacologic support of the status 1 heart transplant candidates (English)

1 reference

11 September 2017

1 reference

Canver CC

1

1 reference

11 September 2017

Chanda J

series ordinal

2

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

The Annals of Thoracic Surgery

11 September 2017

published in

1 reference

11 September 2017

volume

69

1 reference

11 September 2017

issue

6

1 reference

11 September 2017

page(s)

1823-1826

1 reference

Multivariate analysis of factors affecting waiting time to heart transplantation

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901313-8

Mortality remains high for outpatient transplant candidates with prolonged (>6 months) waiting list time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901313-8

Vasodilator and inotropic drugs for the treatment of chronic heart failure: distinguishing hype from hope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901313-8

Effect of phosphodiesterase inhibition on myocardial oxygen consumption and coronary blood flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901313-8

Parenteral inotropic support for advanced congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901313-8

Phosphodiesterase III inhibition or adrenoreceptor stimulation: Milrinone as an alternative to dobutamine in the treatment of severe heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901313-8

Effects of intravenous milrinone on left ventricular function in ischemic and idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901313-8

Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Milrinone-Dobutamine Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901313-8

Home inotropic therapy in advanced heart failure: cost analysis and clinical outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901313-8

Effects of intravenous milrinone followed by titration of high-dose oral vasodilator therapy on clinical outcome and rehospitalization rates in patients with severe heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901313-8

Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901313-8

Milrinone, a bridge to heart transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901313-8

Intravenous milrinone in patients with severe congestive cardiac failure awaiting heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901313-8

Safety and clinical utility of long-term intravenous milrinone in advanced heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2800%2901313-8

10.1016/S0003-4975(00)01313-8

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference